Latest Breaking News On - Pharmaron clinical research facility inpatient unit - Page 1 : comparemela.com

Highlights: Immuron Board approves IMM-529 cGMP manufacturing and to proceed with FDA pre-IND submissionRecruitment and screening update for Travelan® Controlled Human Infection Model (CHIM) Clinical Trial MELBOURNE, Australia, June 22, 2023 (.

United statesSteven lydeamoreDear immuron limited shareholdersImmuron limitedPharmaron clinical research facility inpatient unitControlled human infection modelImmuron limited shareholdersClinical research facility inpatient unit